Default Pathway of var2csa Switching and Translational Repression in Plasmodium falciparum

Antigenic variation is a subtle process of fundamental importance to the survival of a microbial pathogen. In Plasmodium falciparum malaria, PfEMP1 is the major variable antigen and adhesin expressed at the surface of the infected erythrocyte, which is encoded for by members of a family of 60 var-genes. Peri-nuclear repositioning and epigenetic mechanisms control their mono-allelic expression. The switching of PfEMP1 depends in part on variable transition rates and short-lived immune responses to shared minor epitopes. Here we show var-genes to switch to a common gene that is highly transcribed, but sparsely translated into PfEMP1 and not expressed at the erythrocyte surface. Highly clonal and adhesive P. falciparum, which expressed distinct var-genes and the corresponding PfEMP1s at onset, were propagated without enrichment or panning. The parasites successively and spontaneously switched to transcribe a shared var-gene (var2csa) matched by the loss of PfEMP1 surface expression and host cell-binding. The var2csa gene repositioned in the peri-nuclear area upon activation, away from the telomeric clusters and heterochromatin to transcribe spliced, full-length RNA. Despite abundant transcripts, the level of intracellular PfEMP1 was low suggesting post-transcriptional mechanisms to partake in protein expression. In vivo, off-switching and translational repression may constitute one pathway, among others, coordinating PfEMP1 expression

Adaptive Copy Number Evolution in Malaria Parasites

Copy number polymorphism (CNP) is ubiquitous in eukaryotic genomes, but the degree to which this reflects the action of positive selection is poorly understood. The first gene in the Plasmodium folate biosynthesis pathway, GTP-cyclohydrolase I (gch1), shows extensive CNP. We provide compelling evidence that gch1 CNP is an adaptive consequence of selection by antifolate drugs, which target enzymes downstream in this pathway. (1) We compared gch1 CNP in parasites from Thailand (strong historical antifolate selection) with those from neighboring Laos (weak antifolate selection). Two percent of chromosomes had amplified copy number in Laos, while 72% carried multiple (2–11) copies in Thailand, and differentiation exceeded that observed at 73 synonymous SNPs. (2) We found five amplicon types containing one to greater than six genes and spanning 1 to >11 kb, consistent with parallel evolution and strong selection for this gene amplification. gch1 was the only gene occurring in all amplicons suggesting that this locus is the target of selection. (3) We observed reduced microsatellite variation and increased linkage disequilibrium (LD) in a 900-kb region flanking gch1 in parasites from Thailand, consistent with rapid recent spread of chromosomes carrying multiple copies of gch1. (4) We found that parasites bearing dhfr-164L, which causes high-level resistance to antifolate drugs, carry significantly (p = 0.00003) higher copy numbers of gch1 than parasites bearing 164I, indicating functional association between genes located on different chromosomes but linked in the same biochemical pathway. These results demonstrate that CNP at gch1 is adaptive and the associations with dhfr-164L strongly suggest a compensatory function. More generally, these data demonstrate how selection affects multiple enzymes in a single biochemical pathway, and suggest that investigation of structural variation may provide a fast-track to locating genes underlying adaptation

The landscape of inherited and de novo copy number variants in a plasmodium falciparum genetic cross

<p>Abstract</p> <p>Background</p> <p>Copy number is a major source of genome variation with important evolutionary implications. Consequently, it is essential to determine copy number variant (CNV) behavior, distributions and frequencies across genomes to understand their origins in both evolutionary and generational time frames. We use comparative genomic hybridization (CGH) microarray and the resolution provided by a segregating population of cloned progeny lines of the malaria parasite, <it>Plasmodium falciparum</it>, to identify and analyze the inheritance of 170 genome-wide CNVs.</p> <p>Results</p> <p>We describe CNVs in progeny clones derived from both Mendelian (i.e. inherited) and non-Mendelian mechanisms. Forty-five CNVs were present in the parent lines and segregated in the progeny population. Furthermore, extensive variation that did not conform to strict Mendelian inheritance patterns was observed. 124 CNVs were called in one or more progeny but in neither parent: we observed CNVs in more than one progeny clone that were not identified in either parent, located more frequently in the telomeric-subtelomeric regions of chromosomes and singleton <it>de novo </it>CNVs distributed evenly throughout the genome. Linkage analysis of CNVs revealed dynamic copy number fluctuations and suggested mechanisms that could have generated them. Five of 12 previously identified expression quantitative trait loci (eQTL) hotspots coincide with CNVs, demonstrating the potential for broad influence of CNV on the transcriptional program and phenotypic variation.</p> <p>Conclusions</p> <p>CNVs are a significant source of segregating and <it>de novo </it>genome variation involving hundreds of genes. Examination of progeny genome segments provides a framework to assess the extent and possible origins of CNVs. This segregating genetic system reveals the breadth, distribution and dynamics of CNVs in a surprisingly plastic parasite genome, providing a new perspective on the sources of diversity in parasite populations.</p

Comparative Transcriptional and Genomic Analysis of Plasmodium falciparum Field Isolates

Mechanisms for differential regulation of gene expression may underlie much of the phenotypic variation and adaptability of malaria parasites. Here we describe transcriptional variation among culture-adapted field isolates of Plasmodium falciparum, the species responsible for most malarial disease. It was found that genes coding for parasite protein export into the red cell cytosol and onto its surface, and genes coding for sexual stage proteins involved in parasite transmission are up-regulated in field isolates compared with long-term laboratory isolates. Much of this variability was associated with the loss of small or large chromosomal segments, or other forms of gene copy number variation that are prevalent in the P. falciparum genome (copy number variants, CNVs). Expression levels of genes inside these segments were correlated to that of genes outside and adjacent to the segment boundaries, and this association declined with distance from the CNV boundary. This observation could not be explained by copy number variation in these adjacent genes. This suggests a local-acting regulatory role for CNVs in transcription of neighboring genes and helps explain the chromosomal clustering that we observed here. Transcriptional co-regulation of physical clusters of adaptive genes may provide a way for the parasite to readily adapt to its highly heterogeneous and strongly selective environment

A protease cascade regulates release of the human malaria parasite Plasmodium falciparum from host red blood cells

Malaria parasites replicate within a parasitophorous vacuole in red blood cells (RBCs). Progeny merozoites egress upon rupture of first the parasitophorous vacuole membrane (PVM), then poration and rupture of the RBC membrane (RBCM). Egress is protease-dependent1, but none of the effector molecules that mediate membrane rupture have been identified and it is unknown how sequential rupture of the two membranes is controlled. Minutes before egress, the parasite serine protease SUB1 is discharged into the parasitophorous vacuole2,3,4,5,6 where it cleaves multiple substrates2,5,7,8,9 including SERA6, a putative cysteine protease10,11,12. Here, we show that Plasmodium falciparum parasites lacking SUB1 undergo none of the morphological transformations that precede egress and fail to rupture the PVM. In contrast, PVM rupture and RBCM poration occur normally in SERA6-null parasites but RBCM rupture does not occur. Complementation studies show that SERA6 is an enzyme that requires processing by SUB1 to function. RBCM rupture is associated with SERA6-dependent proteolytic cleavage within the actin-binding domain of the major RBC cytoskeletal protein β-spectrin. We conclude that SUB1 and SERA6 play distinct, essential roles in a coordinated proteolytic cascade that enables sequential rupture of the two bounding membranes and culminates in RBCM disruption through rapid, precise, SERA6-mediated disassembly of the RBC cytoskeleton

Improved In Vitro Culture Of Plasmodium Falciparum Permits Establishment Of Clinical Isolates With Preserved Multiplication, Invasion And Rosetting Phenotypes

To be able to robustly propagate P. falciparum at optimal conditions in vitro is of fundamental importance for genotypic and phenotypic studies of both established and fresh clinical isolates. Cryo-preserved P. falciparum isolates from Ugandan children with severe or uncomplicated malaria were investigated for parasite phenotypes under different in vitro growth conditions or studied directly from the peripheral blood. The parasite cultures showed a minimal loss of parasite-mass and preserved percentage of multiple infected pRBCs to that in peripheral blood, maintained adhesive phenotypes and good outgrowth and multiplication rates when grown in suspension and supplemented with gas. In contrast, abnormal and greatly fluctuating levels of multiple infections were observed during static growth conditions and outgrowth and multiplication rates were inferior. Serum, as compared to Albumax, was found necessary for optimal presentation of PfEMP1 at the pRBC surface and/or for binding of serum proteins (immunoglobulins). Optimal in vitro growth conditions of P. falciparum therefore include orbital shaking (50 rev/min), human serum (10%) and a fixed gas composition (5% O2, 5% CO2, 90% N2). We subsequently established 100% of 76 frozen patient isolates and found rosetting with schizont pRBCs in every isolate (&gt;26% schizont rosetting rate). Rosetting during schizogony was often followed by invasion of the bound RBC as seen by regular and time-lapse microscopy as well as transmission electron microscopy. The peripheral parasitemia, the level of rosetting and the rate of multiplication correlated positively to one another for individual isolates. Rosetting was also more frequent with trophozoite and schizont pRBCs of children with severe versus uncomplicated malaria (p&lt;0.002; p&lt;0.004). The associations suggest that rosetting enhances the ability of the parasite to multiply within the human host. © 2013 Ribacke et al.87Carlson, J., Helmby, H., Hill, A.V., Brewster, D., Greenwood, B.M., Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies (1990) Lancet, 336, pp. 1457-1460Kaul, D.K., Roth Jr., E.F., Nagel, R.L., Howard, R.J., Handunnetti, S.M., Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions (1991) Blood, 78, pp. 812-819Miller, L.H., Good, M.F., Milon, G., Malaria pathogenesis (1994) Science, 264, pp. 1878-1883Rowe, A., Obeiro, J., Newbold, C.I., Marsh, K., Plasmodium falciparum rosetting is associated with malaria severity in Kenya (1995) Infect Immun, 63, pp. 2323-2326Silamut, K., Phu, N.H., Whitty, C., Turner, G.D., Louwrier, K., A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain (1999) Am J Pathol, 155, pp. 395-410Pasvol, G., Weatherall, D.J., Wilson, R.J., Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria (1978) Nature, 274, pp. 701-703Friedman, M.J., Erythrocytic mechanism of sickle cell resistance to malaria (1978) Proc Natl Acad Sci U S A, 75, pp. 1994-1997Luzzi, G.A., Merry, A.H., Newbold, C.I., Marsh, K., Pasvol, G., Protection by alpha-thalassaemia against Plasmodium falciparum malaria: modified surface antigen expression rather than impaired growth or cytoadherence (1991) Immunol Lett, 30, pp. 233-240Carlson, J., Nash, G.B., Gabutti, V., Al-Yaman, F., Wahlgren, M., Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation (1994) Blood, 84, pp. 3909-3914Luzzi, G.A., Merry, A.H., Newbold, C.I., Marsh, K., Pasvol, G., Surface antigen expression on Plasmodium falciparum-infected erythrocytes is modified in alpha- and beta-thalassemia (1991) J Exp Med, 173, pp. 785-791Rowe, J.A., Moulds, J.M., Newbold, C.I., Miller, L.H., P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1 (1997) Nature, 388, pp. 292-295Fairhurst, R.M., Baruch, D.I., Brittain, N.J., Ostera, G.R., Wallach, J.S., Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria (2005) Nature, 435, pp. 1117-1121Carlson, J., Wahlgren, M., Plasmodium falciparum erythrocyte rosetting is mediated by promiscuous lectin-like interactions (1992) J Exp Med, 176, pp. 1311-1317Rowe, J.A., Handel, I.G., Thera, M.A., Deans, A.M., Lyke, K.E., Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting (2007) Proc Natl Acad Sci U S A, 104, pp. 17471-17476Fry, A.E., Griffiths, M.J., Auburn, S., Diakite, M., Forton, J.T., Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria (2008) Hum Mol Genet, 17, pp. 567-576Cyrklaff, M., Sanchez, C.P., Kilian, N., Bisseye, C., Simpore, J., Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-infected erythrocytes (2007) Science, 334, pp. 1283-1286Cholera, R., Brittain, N.J., Gillrie, M.R., Lopera-Mesa, T.M., Diakite, S.A., Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin (2008) Proc Natl Acad Sci U S A, 105, pp. 991-996Dondorp, A.M., Desakorn, V., Pongtavornpinyo, W., Sahassananda, D., Silamut, K., Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2 (2005) PLoS Med, 2, pp. e204Chotivanich, K., Udomsangpetch, R., Simpson, J.A., Newton, P., Pukrittayakamee, S., Parasite multiplication potential and the severity of Falciparum malaria (2000) J Infect Dis, 181, pp. 1206-1209Le Scanf, C., Vigan-Womas, I., Contamin, H., Guillotte, M., Bischoff, E., Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey (2008) Microbes Infect, 10, pp. 447-451David, P.H., Handunnetti, S.M., Leech, J.H., Gamage, P., Mendis, K.N., Rosetting: a new cytoadherence property of malaria-infected erythrocytes (1988) Am J Trop Med Hyg, 38, pp. 289-297Wahlgren, M., Carlson, J., Udomsangpetch, R., Perlmann, P., Why do Plasmodium falciparumm-infected erythrocytes form spontaneous erythrocyte rosettes? (1989) Parasitol Today, 5, pp. 183-185Heddini, A., Pettersson, F., Kai, O., Shafi, J., Obiero, J., Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors (2001) Infect Immun, 69, pp. 5849-5856Fernandez, V., Treutiger, C.J., Nash, G.B., Wahlgren, M., Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria (1998) Infect Immun, 66, pp. 2969-2975Al-Yaman, F., Genton, B., Mokela, D., Raiko, A., Kati, S., Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity (1995) Trans R Soc Trop Med Hyg, 89, pp. 55-58Horata, N., Kalambaheti, T., Craig, A., Khusmith, S., Sequence variation of PfEMP1-DBLalpha in association with rosette formation in Plasmodium falciparum isolates causing severe and uncomplicated malaria (2009) Malar J, 8, p. 184Udeinya, I.J., Graves, P.M., Carter, R., Aikawa, M., Miller, L.H., Plasmodium falciparum: effect of time in continuous culture on binding to human endothelial cells and amelanotic melanoma cells (1983) Exp Parasitol, 56, pp. 207-214Biggs, B.A., Kemp, D.J., Brown, G.V., Subtelomeric chromosome deletions in field isolates of Plasmodium falciparum and their relationship to loss of cytoadherence in vitro (1989) Proc Natl Acad Sci U S A, 86, pp. 2428-2432Gysin, J., Pouvelle, B., Fievet, N., Scherf, A., Lepolard, C., Ex vivo desequestration of Plasmodium falciparum-infected erythrocytes from human placenta by chondroitin sulfate A (1999) Infect Immun, 67, pp. 6596-6602Beeson, J.G., Brown, G.V., Molyneux, M.E., Mhango, C., Dzinjalamala, F., Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties (1999) J Infect Dis, 180, pp. 464-472Frankland, S., Adisa, A., Horrocks, P., Taraschi, T.F., Schneider, T., Delivery of the malaria virulence protein PfEMP1 to the erythrocyte surface requires cholesterol-rich domains (2006) Eukaryot Cell, 5, pp. 849-860Frankland, S., Elliott, S.R., Yosaatmadja, F., Beeson, J.G., Rogerson, S.J., Serum lipoproteins promote efficient presentation of the malaria virulence protein PfEMP1 at the erythrocyte surface (2007) Eukaryot Cell, 6, pp. 1584-1594Luginbuhl, A., Nikolic, M., Beck, H.P., Wahlgren, M., Lutz, H.U., Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells (2007) Infect Immun, 75, pp. 1771-1777Scholander, C., Treutiger, C.J., Hultenby, K., Wahlgren, M., Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes (1996) Nat Med, 2, pp. 204-208Clough, B., Atilola, F.A., Black, J., Pasvol, G., Plasmodium falciparum: the importance of IgM in the rosetting of parasite-infected erythrocytes (1998) Exp Parasitol, 89, pp. 129-132Treutiger, C.J., Scholander, C., Carlson, J., McAdam, K.P., Raynes, J.G., Rouleaux-forming serum proteins are involved in the rosetting of Plasmodium falciparum-infected erythrocytes (1999) Exp Parasitol, 93, pp. 215-224Somner, E.A., Black, J., Pasvol, G., Multiple human serum components act as bridging molecules in rosette formation by Plasmodium falciparum-infected erythrocytes (2000) Blood, 95, pp. 674-682Rowe, J.A., Shafi, J., Kai, O.K., Marsh, K., Raza, A., Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria (2002) Am J Trop Med Hyg, 66, pp. 692-699Angeletti, D., Albrecht, L., Blomqvist, K., Quintana Mdel, P., Akhter, T., Plasmodium falciparum Rosetting Epitopes Converge in the SD3-Loop of PfEMP1-DBL1alpha (2012) PLoS One, 7, pp. e50758Normark, J., Nilsson, D., Ribacke, U., Winter, G., Moll, K., PfEMP1-DBL1alpha amino acid motifs in severe disease states of Plasmodium falciparum malaria (2007) Proc Natl Acad Sci U S A, 104, pp. 15835-15840Yeka, A., Banek, K., Bakyaita, N., Staedke, S.G., Kamya, M.R., Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda (2005) PLoS Med, 2, pp. e190Mok, B.W., Ribacke, U., Rasti, N., Kironde, F., Chen, Q., Default Pathway of var2csa switching and translational repression in Plasmodium falciparum (2008) PLoS One, 3, pp. e1982Moll, K., Ljungström, I., Perlmann, H., Scherf, A., (2008) Methods in Malaria Research, , (ed 5th). Manassas, VA, USA and Paris, France 5th editionTreutiger, C.J., Carlson, J., Scholander, C., Wahlgren, M., The time course of cytoadhesion, immunoglobulin binding, rosette formation, and serum-induced agglutination of Plasmodium falciparum-infected erythrocytes (1998) Am J Trop Med Hyg, 59, pp. 202-207Cooke, B.M., Lingelbach, K., Bannister, L.H., Tilley, L., Protein trafficking in Plasmodium falciparum-infected red blood cells (2004) Trends Parasitol, 20, pp. 581-589Deans, A.M., Lyke, K.E., Thera, M.A., Plowe, C.V., Kone, A., Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence (2006) Am J Trop Med Hyg, 74, pp. 554-563Severe falciparum malaria (2009) Trans R Soc Trop Med Hyg, 94, pp. 1-90. , WHO OMolyneux, M.E., Taylor, T.E., Wirima, J.J., Borgstein, A., Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children (1989) Q J Med, 71, pp. 441-459Trager, W., Jensen, J.B., Human malaria parasites in continuous culture. 1976 (2005) J Parasitol, 91, pp. 484-486Butcher, G.A., A comparison of static thin layer and suspension cultures for the maintenance in vitro of Plasmodium falciparum (1981) Ann Trop Med Parasitol, 75, pp. 7-17Allen RJ, Kirk K Plasmodium falciparum culture: the benefits of shaking Mol Biochem Parasitol, 169, pp. 63-65Persson, K.E., McCallum, F.J., Reiling, L., Lister, N.A., Stubbs, J., Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies (2008) J Clin Invest, 118, pp. 342-351Muschiol, S., Bailey, L., Gylfe, A., Sundin, C., Hultenby, K., A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis (2006) Proc Natl Acad Sci U S A, 103, pp. 14566-1457

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs

The emergence of drug resistance is a major limitation of current antimalarials. The discovery of new druggable targets and pathways including those that are critical for multiple life cycle stages of the malaria parasite is a major goal for developing next-generation antimalarial drugs. Using an integrated chemogenomics approach that combined drug resistance selection, whole-genome sequencing, and an orthogonal yeast model, we demonstrate that the cytoplasmic prolyl–tRNA (transfer RNA) synthetase (PfcPRS) of the malaria parasite Plasmodium falciparum is a biochemical and functional target of febrifugine and its synthetic derivative halofuginone. Febrifugine is the active principle of a traditional Chinese herbal remedy for malaria. We show that treatment with febrifugine derivatives activated the amino acid starvation response in both P. falciparum and a transgenic yeast strain expressing PfcPRS. We further demonstrate in the Plasmodium berghei mouse model of malaria that halofuginol, a new halofuginone analog that we developed, is active against both liver and asexual blood stages of the malaria parasite. Halofuginol, unlike halofuginone and febrifugine, is well tolerated at efficacious doses and represents a promising lead for the development of dual-stage next-generation antimalarials.Howard Hughes Medical Institut